Irvington, N.Y.-based skin cancer diagnostic device maker Mela Sciences gets a warning from NASDAQ that it is in danger of being de-listed by the exchange; the company recently cut 25% of staff. Mela Sciences (NSDQ:MELA) was warned by the NASDAQ Stock Market that it must pull its shares above $1.00 or risk being de-listed by the stock exchange. Shares of Mela, the Irvington, N.Y.-based skin cancer diagnostic device maker, haven’t been above the $1 mark since the 1st week of July and are down some 63% in 2013. Shares of MELA closed at 65¢ per share before the holiday weekend.
Help employers find you! Check out all the jobs and post your resume.
